Related references
Note: Only part of the references are listed.Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
Rong Jia et al.
RNA (2019)
CXCL13/CXCR5 signaling axis in cancer
Muzammal Hussain et al.
LIFE SCIENCES (2019)
CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
Marcelo G. Kazanietz et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment
Peter A. van Dam et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
ISG20 promotes local tumor immunity and contributes to poor survival in human glioma
Mengqi Gao et al.
ONCOIMMUNOLOGY (2019)
IL-1 and IL-1 regulatory pathways in cancer progression and therapy
Alberto Mantovani et al.
IMMUNOLOGICAL REVIEWS (2018)
LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer
Liqin Du et al.
Oncotarget (2018)
Current perspective on actinic keratosis: a review
J. A. Siegel et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
C1QBP is upregulated in colon cancer and binds to apolipoprotein A-I
Kun Kim et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study
Pavan B. Narayanaswamy et al.
ONCOTARGET (2017)
variancePartition: interpreting drivers of variation in complex gene expression studies
Gabriel E. Hoffman et al.
BMC BIOINFORMATICS (2016)
EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway
Akifumi Endo et al.
CANCER SCIENCE (2016)
Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis
Tong Wu et al.
SCIENTIFIC REPORTS (2016)
Elevated GAPDH expression is associated with the proliferation and invasion of lung and esophageal squamous cell carcinomas
Lihong Hao et al.
PROTEOMICS (2015)
Identification of reference genes for qRT-PCR in human lung squamous-cell carcinoma by RNA-Seq
Cheng Zhan et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
Subir Biswas et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II-III Resectable Disease
Shanthi Sivendran et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Reduction in lesions from Lmax: a new concept for assessing efficacy of field-directed therapy for actinic keratosis. Results with imiquimod 3.75%
Eggert Stockfleth et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2014)
OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
Lu Cao et al.
BMC CANCER (2013)
Prevalence and awareness of actinic keratosis: Barriers and opportunities
Theodore Rosen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment
Y. Sambandam et al.
ONCOGENE (2013)
Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma Functional analysis and molecular targeting of cyclin-dependent kinase family members in advanced melanoma
Christopher Abdullah et al.
CELL CYCLE (2011)
Gene Expression Patterns of Normal Human Skin, Actinic Keratosis, and Squamous Cell Carcinoma
R. Steven Padilla et al.
ARCHIVES OF DERMATOLOGY (2010)
Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles
Neil Swanson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Actinic Keratoses Natural History and Risk of Malignant Transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Vincent D. Criscione et al.
CANCER (2009)
pathFinder: A Static Network Analysis Tool for Pharmacological Analysis of Signal Transduction Pathways
Babru B. Samal et al.
SCIENCE SIGNALING (2008)
Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod
A. Torres et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up
N. Krawtchenko et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
The burden of skin diseases: 2004 - A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology
David R. Bickers et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists
Kevin S. Gorski et al.
INTERNATIONAL IMMUNOLOGY (2006)
Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer
GJ Chen et al.
DERMATOLOGIC SURGERY (2005)
Imiquimod treatment induces expression of opioid growth factor receptor:: A novel tumor antigen induced by interferon-α?
M Urosevic et al.
CLINICAL CANCER RESEARCH (2004)
Gene expression in actinic keratoses: pharmacological modulation by imiquimod
B Lysa et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
The role of p53 in the immunobiology of cutaneous squamous cell carcinoma
APB Black et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
Share Paper
